Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Legacy Hazardous Drugs
Do Not Tube List
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Report an iCare
Legacy Health
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com)
Contact Pharmacy
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
RCRA
Do Not Crush
Black Box Warning
REMS
Restricted
Legacy Hazardous Drugs
Do Not Tube List
Search results for:
eltrombopag
eltrombopag
Brand names:
Promacta
Form
Strength
POWDER FOR RECONSTITUTION, ORAL
12.5 mg; 25 mg
TABLET, ORAL
12.5 mg; 25 mg; 50 mg; 75 mg
VIEW MORE
Hematopoietic Agents
CLASS
201600
Additional Information:
Inpatient Formulary, with restrictions.
Criteria for use:
Ordered by a hematologist/oncologist
Time to treatment escalation for treating ITP:
At least 3 days of steroids prior to escalation (unless previously documented failure)
At least 2 doses of IVIG prior to escalation (unless previously documented failure)
UNLESS:
Patient is experiencing bleeding or is considered at critical/severe risk of bleeding (platelets < 20,000/mm
3
)
Last updated:
Jul. 1, 2025
Black Box Warning:
Risk for Hepatotoxicity, Restricted Distribution
Restricted
Formulary Restricted Medication
Micromedex
CareNotes
UpToDate
Facts & Comparisons
MedLinePlus (Patient Information)
Inpatient Formulary, with restrictions.
Criteria for use:
UNLESS: